Loading company details...
Beta
Latest Form 4 (Jun 11, 2024): Matthew L. Sherman (EVP & Chief Medical Officer): Grant/Award of 34,157 shares.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2024 | Matthew L. Sherman, EVP & Chief Medical Officer | Grant/Award | 34,157 | n/a |
| Jun 11, 2024 | Thomas Patrick Kelly, Chief Financial Officer | Grant/Award | 34,157 | n/a |
| Jun 11, 2024 | Jama Pitman, SVP, Chief Development Officer | Grant/Award | 20,163 | n/a |
| Jun 11, 2024 | Franklin Stuart Friedman | Tender of Shares | 10,000 | n/a |
| Jun 11, 2024 | Susan L. Kelley | Disposition to Issuer | 24,000 | n/a |
| Jun 11, 2024 | Dashyant Dhanak, EVP & Chief Scientific Officer | Grant/Award | 25,913 | n/a |
| Jun 11, 2024 | John Richard Martin | Disposition to Issuer | 52,000 | n/a |
| Jun 11, 2024 | Daniel C. Martin, Chief Commercial Officer | Grant/Award | 20,163 | n/a |
| Jun 11, 2024 | Dennis Leo Walsh | Tender of Shares | 11,000 | n/a |
| Jun 11, 2024 | James Arthur Bristol | Disposition to Issuer | 22,150 | n/a |